Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence ever issued by the Ministry of Justice for the cultivation of medical cannabis in Colombia.
The granting of this licence positions the Company as the first grower of low tetrahydrocannabinol (“THC”) medical cannabis in the country, and enables the Company to produce low THC based extracts for domestic and international consumption.
The Company currently has two additional licence applications pending approval by the Ministry of Justice and Ministry of Health, and anticipates the issuance of these licences in the near term. These licences would enable the cultivation of high THC based cannabis and production of high THC based cannabis extracts.
Similar to the licence granted for low THC based cannabis by the Ministry of Justice, the Company was the first organization to submit licence applications for the cultivation of high THC based cannabis and production of high THC based cannabis extracts, under the current regulations.
[…]
Read more at Globe Newswire